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Abstract The Id family of hefix-loop-helix proteins function as 
negative regulators of DNA binding, basic helix-loop-helix 
proteins in the regulation of cell growth and differentiation. 
We report here on the identification of a 17 kDa variant of the 14 
kDa Id-3 protein termed Id-3L (long version) which possesses a 
unique 60 amino acid carboxy-terminus generated by read- 
through of a 'coding intron' and alternative splicing. Northern 
analysis revealed expression of a minor 1.1 kb Id-3L transcript 
together with the predominant 0.95 kb Id-3 transcript in the 
majority of adult human tissues analysed. The variant ld-3L 
protein is functionally distinguishable from conventional Id-3 
since in in vitro DNA mobility shift assays, it was greatly 
impaired in its ability to abrogate binding of the basic helix-loop- 
helix protein, E47, to an E box recognition sequence. 
described for the CREM [11] and Drosophila CF2 [12] tran- 
scription factor isoforms. 
We previously reported that the human Id-3 gene displays a 
similar overall organisation of protein-coding sequences to 
that of ld-1, consistent with evolution from a common ances- 
tral Id gene [13]. Specifically, the Id-3 gene harbors a 107 
nucleotide intron interrupting the C-terminal protein coding 
sequence at an analogous position to the coding intron pres- 
ent in Id-1. Despite the disparity in primary sequence between 
the Id-1 and Id-3 genes in this region [13], these observations 
prompted an analysis of the potential of the Id-3 gene to 
encode a variant protein by a similar alternative splicing 
mechanism to that described for Id-1. 
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1. Introduction 
Members of the Id family of helix-loop helix proteins are 
ubiquitously expressed and function at a general level as pos- 
itive regulators of cell growth and negative regulators of 
differentiation [1]. Id functions are thought to be mediated 
primarily through the ability of this class of HLH protein 
to antagonise DNA binding and transcriptional activation 
by members of the somewhat larger family of basic HLH 
proteins, exemplified by the myogenesis-determining MyoD 
protein [2] and the E2A-encoded protein, E47, in B lympho- 
poiesis [3], through the formation of 'inactive' HLH hetero- 
dimers. In addition, Id gene expression is cell cycle regulated 
[4-6] and functional ablation experiments using antisense oli- 
gonucleotide blockade [6,7] and antibody microinjection [8] 
have suggested a role in G1 cell cycle progression, which 
may be intimately linked to control functions in cell growth/ 
differentiation. 
Whilst each of the four known Id genes ( Id - l~)  has been 
shown to encode a single, 14-17 kDa protein [1], three labora- 
tories have reported independently on a variant form of the 
prototype Id-1 protein (Id-IH [7], Id-1.25 [9], Id- lB [10] here- 
inafter referred to as ' Id- lL ')  generated by an alternative 
splicing mechanism which utilises an open reading frame in 
the first intron to generate proteins ranging in size from 13 to 
17 kDa, with a distinct carboxy-terminus [9]. Rat Id- lL  dis- 
plays altered dimerisation properties in being able to form 
stable homodimers in contrast to the conventional 14 kDa 
Id-1 protein [9], and this has been suggested to represent a
mechanism for attenuation of Id function, analogous to that 
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2. Materials and methods 
2.1. Analysis of Id-3 mRNA 
A commercial nylon membrane (Clonetech) loaded with 2 ~tg poly 
A mRNA from various human tissues was used for Northern hybri- 
disation employing either a full length 0.95 kb human Id-3 cDNA 
probe [5] or a 107 nucleotide probe specific for the first intron of 
the human Id-3 gene. This latter probe was generated by PCR (25 
cycles) of a cosmid clone using a 5' primer, 96196 corresponding to 
nucleotides 1040-1061 in Deed et al. [5,13] and a 3' primer, 96197 
corresponding to nucleotides 1121-1145. The same 5' primer was also 
used in combination with a 3' RACE Tag primer (Clonetech) to 
generate a PCR fragment of approx. 0.65 kb from human placental 
cDNA. The identity of this and of the intron-specific PCR product 
was confirmed by nucleotide sequencing as described elsewhere [13]. 
32p labelling of probes, hybridisation and washing were performed 
essentially as described by Deed et al. [5]. Filters were re-probed 
with a glyceraldehyde phosphate dehydrogenase (GAPDH) probe to 
monitor equivalence of RNA loading. 
2.2. Culture of human B cells and immunoprecipitation 
Primary human B cells were isolated and purified from fresh ton- 
sillar tissue essentially as described previously [14]. Briefly, after dis- 
persal of tissue and lymphoprep separation (Flow Laboratories) T 
cells were depleted by incubation with neuraminidase-treated sh ep 
red blood cells (Sigma) and further purified by lymphoprep centrifu- 
gation. Primary B cells and the cell line Reh (immature B cell) were 
cultured in RPMI medium supplemented with 10% FCS (Gibco). For 
[35S]methionine labelling, cells were starved for 1 h in cysteine-methio- 
nine free medium (ICN-Flow Laboratories) containing 5% dialysed 
FCS and then incubated for an additional 2 h in fresh medium sup- 
plemented with 200 I.tCi/ml of 'Promix' (Amersham, spec. act. 1000 Ci 
mmol-1). As appropriate, cells were stimulated with the phorbol ester, 
PMA (30 nM) for 5 h prior to harvest. Labelled cells were harvested 
by first being washed once in PBS and then lysed in RIPA buffer (50 
mM Tris-HC1, pH. 8.0, 150 mM NaC1, 1% NP40, 0.1% SDS, 0.5% 
sodium deoxycholate), supplemented with the following protease in- 
hibitors: 0.1 mM PMSF, 100 jxg/ml each of leupeptin, bestatin, apro- 
tinin and 2 mM levamisole. 
Prior to immune precipitation, lysates were sheared by passage 
through a 19 g needle and particulate matter was collected by centri- 
fugation at 2500 rpm for 3 min in a refrigerated microfuge. The cell 
lysate was pre-cleared by incubation with 10 txl of normal rabbit sera 
and 50 ~tl of protein A/G Sepharose beads (Santa Cruz Biotechnology, 
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USA) for 30 min at 4°C with agitation. Supernatants were recovered 
by centrifugation and used in subsequent immune precipitations. For 
each immunoprecipitation reaction, 500 gl of cleared lysate was in- 
cubated with 5 gl of Id-3 specific antiserum, RD6 (raised against a full 
length Id-3 protein; Deed et al., unpublished) and rocked for 1 h at 
4°C, after which 30 ?.tl of protein A/G Sepharose beads was added and 
the incubation continued for a further 1 h. The immune complexed 
antigens were pelleted by centrifugation and washed four times with 
lysis buffer then finally re-suspended and boiled for 5 min in SDS 
sample buffer. The precipitated antigens were fractionated on a 12% 
SDS-polyacrylamide g l and fluorographed essentially as described 
previously [5]. 
2.3. In vitro transcription and translation 
Constructs of Id-3 and Id-3L in the plasmid pcDNA3, (Invitrogen) 
were linearised with the enzyme XbaI and 2 I.tg was transcribed for 2 h 
at 37°C with T7 polymerase using a commercial kit (Promega UK) 
employing conditions recommended by the supplier. A 250 bp frag- 
ment of a truncated E47 cDNA [15] cloned into the pBluescript plas- 
mid was linearised with the enzyme EcoRI for in vitro transcription 
with T3 polymerase. In vitro translation using a rabbit reticulocyte 
lysate system (Promega, UK) was carried out essentially according to 
the manufacturer's instructions typically using one tenth of the tem- 
plate RNA generated by in vitro transcription above. Radiolabelled 
protein was generated by performing parallel reactions incorporating 
[35S]methionine (spec. act. 1000 Ci mmo1-1, Amersham, UK). Result- 
ing proteins were analysed on 12.5% SDS-polyacrylamide g ls or by 
DNA mobility band shift assay [5]. 
2.4. DNA mobility shift assay 
A 20 bp double-stranded oliogonucleotide containing the wild-type 
E box recognition sequence, ACCTGAACAGATGGTCGGCT or 
mutant: ACCTGAACCGATTGTCGGCT (the E-box element is 
shown in bold and differencesare underlined), was used in all reac- 
tions to assay for E47 homodimer binding essentially as described 
previously [5]. Competition reactions with either wild-type or mutant 
probe (above) established the specificity of the reaction (data not 
shown). DNA mobility shift assays were carried out essentially as 
described by Murre et al. [16]. Oligonucleotides were self-annealed, 
5' end-labelled using [y-a2p]ATP (spec. act. 3000 Ci mmo1-1, Amer- 
sham, UK) with polynucleotide kinase and subsequently purified on a 
polyacrylamide g l. Equimolar equivalence of Id-3 and Id-3L proteins 
was determined by [35S]methionine incorporation and normalisation 
with respect o methionine content of the translated proteins. Approx. 
4× 104 cpm of labelled oligonucleotide was incubated in a final vol- 
ume of 10 /al of programmed or unprogrammed rabbit reticulocyte 
lysate. Each binding reaction was carried out by first incubating the 
lysate at 37°C for 20 min in binding buffer comprising 10 mM Tris pH 
7.4, 50 mM NaC1, 1 mM DTT, 1 mM EDTA. Subsequently, 1pg of 
poly(dlC:dlC) (Sigma) was added as a non-specific ompetitor and 
incubated for a further 20 min. Finally, the probe was added and the 
incubation was continued for a further 20 min at 37°C prior to anal- 
ysis on a 5% non-denaturing polyacrylamide gel essentially as de- 
scribed previously [5]. 
3. Results and discussion 
Previously, we identified a 107 nucleotide intron located 
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Fig, 1. Schematic representation f the structure and predicted ami- 
no acid sequences of Id-3 and the spliced variant Id-3L. Data for 
nucleotide/amino acid sequence were taken from [5,13]. The relative 
positions of the regions common to Id-3 and Id-3L, encompassing 
the HLH domain, are depicted by open boxes, and the amino acid 
sequences of the carboxy termini unique to each protein are shown. 
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Fig. 2. Expression of Id-3 and Id-3L transcripts in human tissues. 
Replicate Northern blots were hybridised with either a full length 
Id-3 cDNA probe or with a 107 nucleotide, PCR-generated probe 
specific for the first intron of the human Id-3 gene. The membrane 
was re-probed with a GAPDH probe as a control for loading. Sizes 
of fragments were estimated relative to RNA markers (Clontech). 
PBL, peripheral blood lymphocytes (resting). 
near the C-terminal coding region of the Id-3 gene in a region 
that is also interrupted by a short intron sequence in the Id-1 
gene [13]. As shown in Fig. 1, the nucleotide sequence of this 
Id-3 intron predicts an open reading frame contiguous with 
that of the first 100 amino acids of the prototype Id-3 protein. 
The open reading frame continues beyond the intron sequence 
and into the second exon after which it terminates at a posi- 
tion just downstream of the prototype Id-3 termination co- 
don. The size of the predicted protein, which we have desig- 
nated 'Id-3L' (long version of Id-3) is 160 amino acids 
compared with 119 amino acids for the prototype Id-3 protein 
(Fig. 1) and, because the two predicted proteins utilise alter- 
nate open reading frames in the second exon region, they each 
have a unique C-terminus, 19 amino acids long in the case of 
Id-3 and 60 amino acids long for Id-3L. 
Northern blot analysis of RNA from primary tissues (Fig. 
2) and from various cell lines (data not shown) using a full 
length Id-3 cDNA probe, revealed, in addition to the predom- 
inant 0.95 kb Id-3 transcript, a less abundant 1.1 kb tran- 
script, consistent with an Id-3L mRNA generated by alterna- 
tive splicing. As shown in Fig. 2, this 1.1 kb transcript (but 
not the 0.95 kb Id-3 transcript) was indeed detected with an 
intron-specific probe. PCR analysis of human placental 
cDNA using a primer flanking the 5' boundary of the intron 
in combination with a 3' RACE Tag primer followed by nu- 
cleotide sequencing (see Section 2) confirmed the presence of 
the alternatively spliced Id-3L transcript (data not shown). 
Most cell types/tissues expressing the 0.95 kb Id-3 transcript 
also expressed the 1.1 kb Id-3L mRNA,  albeit at lower abun- 
dance. One exception was spleen, in which Id-3L was barely 
detectable (Fig. 2). 
In common with most other early response genes, Id genes 
display a peak level of expression a few hours following mi- 
togenic stimulation of quiescent cells, prior to the G1/S tran- 
sition of the cell cycle [5-8]. Northern blot analysis for Id-3 
and Id3-L encoding transcripts identified identical kinetics of 
induction following mitogenic stimulation of quiescent B cells 
(data not shown). To determine whether the Id-3L mRNA is 
translated in vivo, we examined Id-3 protein in stimulated 
primary human B cells which are particularly abundant in 
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this class of Id protein (Norton and Deed, unpublished ob- 
servations). As shown in Fig. 3, resting (Go) B cells barely 
yielded detectable Id-3 protein following [35S]methionine la- 
belling and immunoprecipitation with antibody raised against 
the full length Id-3 protein. Following mitogenic stimulation 
however, both the 15 kDa Id-3 protein together with a very 
minor 17 kDa species representing a candidate Id-3L protein, 
(poorly visible in Fig. 3) became detectable. Neither protein 
species was immune precipitable using pre-immune serum as a 
control (Fig. 3). In exponentially growing cells from the im- 
mature B cell line Reh, the candidate 17 kDa Id-3L protein 
was more easily detectable (Fig. 3). 
The functional role of the alternatively spliced Id- lL pro- 
tein is currently unknown [7,9,10]. The only reported iffer- 
ence between this and the prototype Id-1 protein, is in homo- 
dimerisation potential [9]. Whilst Id- lL readily forms stable 
homodimers, Id-1 does not and this has been suggested to 
represent a potential mechanism of negatively regulating Id 
function by sequestering Id- lL into an 'inert' homodimer con- 
figuration [9]. However, we recently found that the prototype 
Id-3 protein itself forms stable homodimers (in contrast to Id- 
1) by virtue of favourable charge-charge interaction at the 
dimer interface [17]. As an alternative functional property, 
we therefore compared the ability of Id-3 and Id-3L to form 
stable heterodimers with the bHLH protein E47, thereby ab- 
rogating binding to an 'E box' recognition sequence in band 
shift assays. Initially, in vitro translations were programmed 
to generate quivalent molar yields of the Id-3 and Id-3L 
proteins (Fig. 4A). Increasing inputs of these translates were 
then compared with an unprogrammed lysate (UP) for their 
ability to ablate the appearance of the E47 homodimer band 
shift as shown in Fig. 4B. In these experiments, E box binding 
to the USF protein which arises as an endogenous activity in 
reticulocyte in vitro translations ( ee [5]), provides a conveni- 
ent internal control. Consistent with previous tudies [4,5], the 
prototype Id-3 protein readily blocked E47 binding to DNA. 
However, translates programmed for Id-3L led to only a mi- 
nor diminution of E47-E box binding at the highest input and 
even this was only marginally higher than that seen with un- 
programmed lysate (Fig. 4B). Thus, we conclude that the 
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Fig. 3. Analysis of Id-3/Id-3L proteins in human B cells by immune 
precipitation. Purified human tonsillar B cells (l°B) were cultured in 
either the presence or absence of the phorbol ester PMA (30 nM) 
as indicated for 5 h. Cells were labelled with [35S]methionine for 2 h 
then lysed and analysed by immune precipitation using either con- 
trol pre-immune serum or anti-Id-3 (RD6) serum raised against a 
full length, bacterially synthesized I -3 protein. Exponentially grow- 
ing cells from the B cell line, Reh, were [35S]methionine labelled for 
2 h and similarly analysed by immune precipitation. Autoradio- 
graphs of 12% SDS-polyacrylamide gels are shown after exposure 
for 4 days. 
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Fig. 4. Analysis of Id-3 and Id-3L function by DNA mobility shift 
assay. (A) In vitro translates of [a5S]methionine-labelled proteins 
either unprogrammed (--RNA) or programmed with Id-3 or Id-3L 
transcripts were analysed on a 12% polyacrylamide g l. (B) Band 
shift analysis using a 35p-labelled E box probe (control, lane P) after 
incubation with unprogrammed lysate (-RNA) or with in vitro 
translated E47 protein are shown. Incubations were challenged with 
increasing input (5, 10 and 15 I.tl) of competitor, either as control, 
unprogrammed lysate (UP) or with lysate programmed with Id-3 or 
Id-3L as indicated. In vitro translations of Id-proteins were per- 
formed in parallel with those shown in (A) except without labelled 
methionine and molar equivalence of Id-3 and Id-3L protein inputs 
were verified in further experiments (data not shown). The retarded 
complex labelled 'USF' arises from a contaminant in unpro- 
grammed reticulocyte lysate (see control ' -RNA'  lane) and provides 
a convenient internal control [5]. 
ability of Id-3L to antagonise E47 binding to DNA is greatly 
impaired compared to that of the prototype Id-3. 
Molecular modelling and site-directed mutagenesis studies 
have clearly established that the HLH domain is the primary 
determinant of dimerisation potential of Id (and bHLH) pro- 
teins [17-19]. Our data on Id-3L and that previously reported 
for Id- lL [9] now illustrate that domains well removed from 
the HLH region can have a dramatic effect on dimerisation 
function. Whilst the principal effect of generating an alterna- 
tive carboxyterminus at least for the Id-3 protein appears to 
result in a 'loss of function' variant, as discussed previously 
for Id-1 [9,10], such alterations in dimerisation specificity may 
manifest in enhanced affinity for other bHLH targets which 
are not normally involved in dimerisation with conventional 
Id proteins. Alternatively, IdL proteins may target nuclear 
transcriptional effectors which do not belong to the bHLH 
family, such as the recently described MIdA1 binding partner 
for Id-1 [20], or the tumour suppressor protein, Rb which 
reportedly binds Id-2 [21]. 
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